Teva Pharmaceutical Industries Article Index for
Teva
Website Links For
Teva
 

Information About

Teva Pharmaceutical Industries




  Company Logo
  Company Type Public ()
  Foundation 1901
  Location City Petah Tikva
  Location Country Israel
  Key People Shlomo Yanai , President and Chief Executive Officer
  Industry Pharmaceutical
  Products Pharmaceuticals
  Homepage http://wwwtevapharmcom/


Teva Pharmaceutical Industries Ltd. (Hebrew: טבע תעשיות פרמצבטיות בע"מ), is an international Pharmaceutical Company headquartered in Israel . It specializes in Generic and Proprietary pharmaceuticals and active pharmaceutical ingredients. It is the largest generic Drug manufacturer in the world and one of the 20 largest pharmaceutical companies worldwide. In 2006, its sales totaled $8.4 billion, of which 80% in Europe and North America. After its acquisition of U.S. rival Ivax Corporation in January 2006, the company has about 26,000 employees in 50 countries. Teva's facilities are located in Israel, North America, Europe and Latin America.


HISTORY


Teva, founded in 1901, was originally founded as Salomon, Levin, and Elstein Ltd., a wholesale distributor based in Jerusalem . During the 1930s new immigrants from Europe founded several pharmaceutical companies including Teva, Assia, and Zori. In 1951 , Teva raised capital through the newly founded Tel-Aviv Stock Exchange

In 1964 Assia and Zori merged and acquired a controlling interest in Teva. In 1976 , these three companies merged into the modern Teva Pharmaceutical Industries Ltd. In 1980 , Teva continued to follow its vision of becoming one of the world's biggest Pharmaceutical companies by acquiring then Israel's second largest drug manufacturer, Ikapharm.
http://www.tevapharm.com/about/history.asp The History of Teva

In 1982 Teva was granted FDA approval for its Kfar Saba manufacturing plant, an essential milestone for marketing Pharmaceuticals in the USA.

On June 23, 2006, Teva (through a former Ivax subsidiary) received from the U.S. Food & Drug Administration a 180-day exclusivity period to sell Simvastatin (Zocor) in the U.S. as a Generic Drug in all strengths except 80 mg. Teva presently competes with the maker of brand-name Zocor, Merck & Co. ; Ranbaxy Laboratories , which has 180-day exclusivity at 80 mg; and Dr. Reddy's Laboratories , whose authorized generic version (licensed by Merck) is exempt from exclusivity.


PRODUCTS


Pharmaceuticals



SUBSIDIARIES




ANIMAL RIGHTS ARRESTS

Two Israeli animal rights activists were charged with "illegal gathering" in Petah-Tikva, Israel, after being arrested in December 2006 for holding a vigil outside TEVA's offices. The activists were protesting because TEVA is a client of Huntingdon Life Sciences (HLS), which is the focus of an international animal rights campaign, Stop Huntingdon Animal Cruelty . "Two Israeli activists charged with 'illegal gathering'" , ''Arkangel'', undated.


REFERENCES




EXTERNAL LINKS